Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

895 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project.
Hikino K, Ozeki T, Koido M, Terao C, Kamatani Y, Mizukawa Y, Shiohara T, Tohyama M, Azukizawa H, Aihara M, Nihara H, Morita E, Murakami Y, Kubo M, Mushiroda T. Hikino K, et al. Among authors: tohyama m. Clin Pharmacol Ther. 2020 May;107(5):1170-1178. doi: 10.1002/cpt.1706. Epub 2019 Dec 6. Clin Pharmacol Ther. 2020. PMID: 31646624
Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T. Kano Y, et al. Among authors: tohyama m. J Dermatol. 2015 Mar;42(3):276-82. doi: 10.1111/1346-8138.12770. Epub 2015 Jan 27. J Dermatol. 2015. PMID: 25623158
The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
Sunaga Y, Kurosawa M, Ochiai H, Watanabe H, Sueki H, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Hama N, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Kokaze A. Sunaga Y, et al. Among authors: tohyama m. J Dermatol Sci. 2020 Dec;100(3):175-182. doi: 10.1016/j.jdermsci.2020.09.009. Epub 2020 Sep 28. J Dermatol Sci. 2020. PMID: 33046331
Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients.
Sunaga Y, Hama N, Ochiai H, Kokaze A, Lee ES, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Sueki H. Sunaga Y, et al. Among authors: tohyama m. J Dermatol Sci. 2022 Aug;107(2):75-81. doi: 10.1016/j.jdermsci.2022.07.004. Epub 2022 Jul 13. J Dermatol Sci. 2022. PMID: 35882616
Confusion in determination of two types of cutaneous adverse reactions to drugs, maculopapular eruption and erythema multiforme, among the experts: A proposal of standardized terminology.
Hashizume H, Abe R, Azukizawa H, Fujiyama T, Hama N, Mizukawa Y, Morita E, Nakagawa Y, Nakajima S, Niihara H, Teraki Y, Tohyama M, Watanabe H, Tokura Y; Drug Allergy Database Committee in Japanese Cutaneous Immunology and Allergy Association. Hashizume H, et al. Among authors: tohyama m. J Dermatol. 2020 Feb;47(2):169-173. doi: 10.1111/1346-8138.15164. Epub 2019 Nov 28. J Dermatol. 2020. PMID: 31782184
Predictive Factors Associated With Acute Ocular Involvement in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Sotozono C, Ueta M, Nakatani E, Kitami A, Watanabe H, Sueki H, Iijima M, Aihara M, Ikezawa Z, Aihara Y, Kano Y, Shiohara T, Tohyama M, Shirakata Y, Kaneda H, Fukushima M, Kinoshita S, Hashimoto K; Japanese Research Committee on Severe Cutaneous Adverse Reaction. Sotozono C, et al. Among authors: tohyama m. Am J Ophthalmol. 2015 Aug;160(2):228-237.e2. doi: 10.1016/j.ajo.2015.05.002. Epub 2015 May 13. Am J Ophthalmol. 2015. PMID: 25979679
Differential expression profile of Th1/Th2-associated chemokines characterizes Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS) as distinct entities.
Miyagawa F, Hasegawa A, Imoto K, Ogawa K, Kobayashi N, Ito K, Fujita H, Aihara M, Watanabe H, Sueki H, Tohyama M, Asada H. Miyagawa F, et al. Among authors: tohyama m. Eur J Dermatol. 2015 Jan-Feb;25(1):87-9. doi: 10.1684/ejd.2014.2477. Eur J Dermatol. 2015. PMID: 25547780 No abstract available.
Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS).
Ogawa K, Morito H, Hasegawa A, Miyagawa F, Kobayashi N, Watanabe H, Sueki H, Tohyama M, Hashimoto K, Kano Y, Shiohara T, Ito K, Fujita H, Aihara M, Asada H. Ogawa K, et al. Among authors: tohyama m. Br J Dermatol. 2014 Aug;171(2):425-7. doi: 10.1111/bjd.12948. Epub 2014 Aug 2. Br J Dermatol. 2014. PMID: 24601914 No abstract available.
High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome.
Onuma H, Tohyama M, Imagawa A, Hanafusa T, Kobayashi T, Kano Y, Ohashi J, Hashimoto K, Osawa H, Makino H; Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research; Japanese Dermatological Association. Onuma H, et al. Among authors: tohyama m. J Clin Endocrinol Metab. 2012 Dec;97(12):E2277-81. doi: 10.1210/jc.2012-2054. Epub 2012 Oct 15. J Clin Endocrinol Metab. 2012. PMID: 23071161 Review.
[Drug-induced hypersensitivity syndrome].
Tohyama M. Tohyama M. Nihon Rinsho. 2012 Aug;70 Suppl 6:498-502. Nihon Rinsho. 2012. PMID: 23156558 Japanese. No abstract available.
895 results